000 01279 a2200397 4500
005 20250512004810.0
264 0 _c19890523
008 198905s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1989.81
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVirgolini, I
245 0 0 _aHuman hepatocellular cancers show decreased prostaglandin E1 binding capacity.
_h[electronic resource]
260 _bBritish journal of cancer
_cMar 1989
300 _a407-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAlprostadil
_xmetabolism
650 0 4 _aBinding, Competitive
650 0 4 _aCarcinoma, Hepatocellular
_xmetabolism
650 0 4 _aCell Membrane
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProstaglandins
_xmetabolism
650 0 4 _aReceptors, Prostaglandin
_xmetabolism
650 0 4 _aReceptors, Prostaglandin E
700 1 _aSinzinger, H
700 1 _aMüller, C
700 1 _aHermann, M
773 0 _tBritish journal of cancer
_gvol. 59
_gno. 3
_gp. 407-9
856 4 0 _uhttps://doi.org/10.1038/bjc.1989.81
_zAvailable from publisher's website
999 _c2545136
_d2545136